A unified pathophysiologic construct of diabetes and its complications, including malignancies, in the context of the B-cell classification of diabetes: opportunities for drug design
which alters metabolic pathways a la Brownlee’s Hypothesis model, alterations in gene expression, epigenetics, and inflammation. This unified pathophysiologic approach to the complications of diabetes in the context…

